| 13th Mar 2017 7:00 am |
RNS |
Final Results |
| 10th Mar 2017 8:11 am |
RNS |
Sulfatinib Phase Ib/II Results Presented at ENETS |
| 10th Mar 2017 7:18 am |
RNS |
Sulfatinib Phase Ib/II Results Presented at ENETS |
| 7th Mar 2017 11:49 am |
EQS |
Edison issues update on Hutchison China Meditech (HCM) |
| 3rd Mar 2017 7:00 am |
RNS |
Positive Fruquintinib Pivotal Phase III Results |
| 28th Feb 2017 10:20 am |
RNS |
Change of Directors |
| 20th Feb 2017 7:00 am |
RNS |
Start of Phase II Savolitinib PSC trial in China |
| 14th Feb 2017 7:07 am |
RNS |
Initiates Phase I of Novel FGFR Inhibitor HMPL-453 |
| 14th Feb 2017 7:00 am |
RNS |
Savolitinib PRCC Results Presentation at ASCO GU |
| 6th Feb 2017 7:00 am |
RNS |
Chi-Med to Announce 2016 Final Results |
| 1st Feb 2017 7:00 am |
RNS |
Change of Directors |
| 16th Jan 2017 10:48 am |
RNS |
Change of Directors |
| 16th Jan 2017 10:11 am |
RNS |
Change of Directors |
| 16th Jan 2017 7:30 am |
RNS |
Fruquintinib Phase I/II Clinical Data at ASCO GI |
| 16th Jan 2017 7:29 am |
RNS |
Sulfatinib Phase II Study in 2nd Line BTC in China |
| 16th Jan 2017 7:16 am |
RNS |
Fruquintinib Combination Study in 1st-Line NSCLC |
| 10th Jan 2017 7:00 am |
RNS |
Chi-Med Initiates HMPL-523 Clinical Trials |
| 30th Dec 2016 9:11 am |
RNS |
Total Voting Rights |
| 29th Dec 2016 7:40 am |
RNS |
Blocklisting Six Monthly Return |
| 20th Dec 2016 7:18 am |
RNS |
Director's Share Dealing |
| 14th Dec 2016 7:14 am |
RNS |
Director's Share Dealing |
| 6th Dec 2016 7:00 am |
RNS |
HMPL-523 Pre-clinical Data Presented at ASH |
| 30th Nov 2016 7:51 am |
RNS |
Exercise of Share Options |
| 30th Nov 2016 7:48 am |
RNS |
Total Voting Rights |
| 23rd Nov 2016 7:34 am |
RNS |
Director's Share Dealing |
| 23rd Nov 2016 7:30 am |
RNS |
Chi-Med to Present Data at the 17th WCLC |
| 23rd Nov 2016 7:08 am |
RNS |
Chi-Med to Present Data at the at the 17th WCLC |
| 14th Nov 2016 9:06 am |
RNS |
Chi-Med Presents Ph I Clinical Data for HMPL-523 |
| 1st Nov 2016 2:57 pm |
RNS |
Director's Share Dealing |
| 31st Oct 2016 7:00 am |
RNS |
Joint Venture - US$59.5m Land Compensation Payment |
| 12th Oct 2016 7:00 am |
RNS |
Director's Share Dealing |
| 9th Aug 2016 8:07 am |
RNS |
Director's Share Dealing |
| 2nd Aug 2016 8:18 am |
RNS |
Change of Non-executive Directors |
| 2nd Aug 2016 7:00 am |
RNS |
Chi-Med 2016 Interim Results |
| 1st Aug 2016 7:21 am |
RNS |
Chi-Med and AstraZeneca to Accelerate Savolitinib |
| 5th Jul 2016 7:00 am |
RNS |
Chi-Med to Announce 2016 HY Financial Results |
| 29th Jun 2016 7:00 am |
RNS |
Blocklisting Six Monthly Return |
| 20th Jun 2016 7:00 am |
RNS |
Savolitinib Global Phase II Trial Initiated |
| 15th Jun 2016 8:09 am |
RNS |
Additional Listing |
| 31st May 2016 7:00 am |
RNS |
Total Voting Rights |
